0001209191-13-027552.txt : 20130520
0001209191-13-027552.hdr.sgml : 20130520
20130520162222
ACCESSION NUMBER: 0001209191-13-027552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130516
FILED AS OF DATE: 20130520
DATE AS OF CHANGE: 20130520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUELLER PETER
CENTRAL INDEX KEY: 0001256126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 13858644
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-05-16
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001256126
MUELLER PETER
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
EVP, Global R&D, CSO
Common Stock
2013-05-16
5
G
0
E
10352
0.00
D
0
I
Shares held by GRATS
Common Stock
5568
I
Revocable Trusts
Common Stock
4770
I
401(k)
Common Stock
144400
D
On May 16, 2013, grantor retained annuity trusts (GRATS) established by Dr. Mueller in 2010 that held 15,920 shares of common stock terminated in accordance with the terms of the GRATs. 10,352 shares were transferred to a trust established for the benefit of Dr. Mueller's adult child. The remaining 5,568 shares were distributed to revocable trusts established for the benefit of Dr. Mueller and his wife and are reported on this Form 4 as indirectly owned.
Kenneth L. Horton, Attorney-In-Fact
2013-05-20